NorthWest Biotherapeutics Inc (NWBO)

[HappyLibrarian]

I do not know how NWBO management could be believed to have thought that when the company line pounded day after day by their surrogates was that the journal article was vital to protect a TLD release from being attacked by shorts and that the data could not speak for itself. That company line, as communicates by surrogates only changed when the May 10th event happened.

Further, defending the share price has never been an officially expressed priority for NWBO management and the actions of management if anything always seem to undercut rallies generated by shareholders not only by the strategic withholding of steady communication but by the way things are communicated when a rally is moving along. This pattern has been expressed by others as well, and it does sometimes seem like management wants the share price low for one reason or another despite the heavier dilutive effect that has on the shareholders who they nominally have a fiduciary duty towards.

Why they are doing these weird things is hard to figure out but I am sure it is all perfectly legal.